Skip to content
Home/Companies/MedTech/ReCor Medical
RM

ReCor Medical

MedTech·US·Exited 2018·Held 2yr

ReCor Medical is a healthcare / medtech company, headquartered in United States.

Entry
2016
Hold
2yr
Exit
2018
Est. EV
–

Who owns ReCor Medical?

ReCor Medical was owned by Sofinnova Partners through Sofinnova Capital VIII (2015 vintage) from 2016 to 2018, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-04-21

Sofinnova Partners
Investor
Sofinnova Partners
Sofinnova Capital VIII · 2015 · Life Sciences VC

Key facts

HQUnited States
SectorHealthcare / Medtech
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2018

More from Sofinnova Capital VIII

Other portfolio companies in the same fund.

VectivBio
Exited 2023
BiotechSwitzerland· 2017
to
Breath Therapeutics
Exited 2019
BiotechGermany· 2016
to
Corvidia Therapeutics
Exited 2020
BiotechUS· 2016
to
Delinia
Exited 2017
BiotechUK· 2016
to
ENYO Pharma
Active
BiotechFrance· 2016
BiovelocITA
Active
BiotechItaly· 2015

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Aflo
Active
Clarendon Fund ManagersUnited Kingdom
Lattice Medical
Active
Finovam GestionFrance
QTAS
Active
OVNI CapitalGermany
Axomove
Active
Go CapitalFrance· 2026
Bioliberty
Active
Scottish National Investment BankUK· 2026
CertHub
Active
Cusp Capital PartnersGermany· 2026
Data refreshed weekly · Sourced from public filings